AUTOINFLAMMATORY DISEASES IN RHEUMATOLOGY: RUSSIAN EXPERIENCE

Autoinflammatory diseases (AIDs) are characterized by periodic, sometimes self-limiting attacks that appear as fever and clinical symptoms resembling rheumatic ones, in the absence of autoimmune or infectious diseases. The group of AIDs encompasses a broad spectrum of nosological entities; some of them have been recently dealt with by rheumatologists.

Objective: to define the spectrum of AIDs in the practice of a pediatric rheumatologist from the results of visits to the Russian Federal Rheumatology Center.

Subjects and methods. The investigation enrolled patients who had visited the V.A. Nasonova Research Institute of Rheumatology in 2007 to 2015 for fever and other signs of a systemic inflammatory process in order to specify their diagnosis and to rule out infections, blood cancer, and other diseases. All underwent conventional rheumatologic examination, HLA Class A typing, and molecular genetic testing.

Results and discussion. 101 patients aged 6.5 months to 60 years with AIDs were identified over 9 years and diagnosed as having the following diseases. Familial Mediterranean fever (FMF) was detected in 17 patients (the female to male (M/F) ratio was 6:11); Behсet's disease (BD) in 25 children (M/F, 14:11), cryopyrin-associated periodic syndromes (CAPS) in 17 patients, including Muckle–Wells syndrome in 13 (M/F, 4:9); chronic infantile neurologic cutaneous articular and neonatal onset multisystem inflammatory disease (CINCA/NOMID) syndrome in 4 (M/F, 3:1), periodic fever, aphthous stomatitis, pharyngitis, cervical adenitis (PFAPA) syndrome in 17 (M/F, 10:7), hyper-IgD syndrome/mevalonate kinase deficiency syndrome in 3 (M/F, 0:3), tumor necrosis factor receptor periodic syndrome (TRAPS) in 7 (M/F, 4:3), undifferentiated AID in 14, and Blau syndrome in one patient. The patients with BD were rather ethnically diverse: among them, there were representatives of North Caucasian peoples, Tatars, Uzbeks, Moldavians, and others; there were 7 ethnic Russians. There was a preponderance of Armenians among FMF patients (15/17). Ethnic Russians were predominant among the patients with other nosological entities. HLA-B5 antigen was found in 9 (36%) patients with BD. Molecular genetic analysis confirmed the diagnosis in virtually all the patients with monogenic AIDs.

Conclusion. The most common AIDs in our practice were BD, FMF, CAPS, and PFAPA. The patients with CAPS were closest in clinical and laboratory presentations to those with rheumatic disease, particular to those diagnosed with systemic juvenile arthritis and this disease should be kept in mind in differential diagnosis. Our practical experience indicated that targeted therapy with interleukin 1 inhibitors was effective in CAPS patients. This treatment is able to substantially improve an initial poor prognosis.

1. Fietta P. Autoinflammatory diseases: the hereditary periodic fever syndromes. Acta Biomed. 2004;75(2):92-9.

2. Кузьмина НН, Салугина СО, Федоров ЕС. Аутовоспалительные заболевания и синдромы у детей: Учебно-методическое пособие. Москва: ИМА-ПРЕСС; 2012. 104 с. [Kuz’mina NN, Salugina SO, Fedorov ES. Autovospalitel'nye zabolevaniya i sindromy u detei: Uchebnometodicheskoe posobie [Autoinflammatory diseases and syndromes in children: Teaching manual]. Moscow: IMA-PRESS; 2012. 104 p.].

3. Kuijk LM, Hoffman HL, Neven B, Frenkel J. Episodic autoinflammatory disorders in children. In: Handbook of Systemic Autoimmune Disease. Vol. 6. Pediatrics in Systemic Autoimmune Disease. Cimas R, Lehman T, eds. Elsevier; 2008. P. 119-35.

4. Goldbach-Mansky R, Kastner DL. Autoinflammation: The prominent role of IL-1 in monogenic autoinflammatory diseases and implication for common illnesses. J Allergy Clin Immunol. 2009;124:1141-51. doi: 10.1016/j.jaci.2009.11.016

5. Ильина АЕ, Станислав МЛ, Денисов ЛН, Насонов ЕЛ. Интерлейкин 1 как медиатор воспаления и терапевтическая мишень. Научно-практическая ревматология. 2011;49(5):62-71 [Il’ina AE, Stanislav ML, Denisov LN, Nasonov EL. Interleukin-1 as a mediator of inflammation and therapeutic target. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2011;49(5):62-71 (In Russ.)]. doi: 10.14412/1995-4484-2011-1463

6. Federici S, Martini A, Gattorno M. The central role of anti-IL-1 blockade in the treatment of monogenic and multi-factorial autoinflammatory diseases. Front Immunol. 2013;4:351. doi: 10.3389/fimmu.2013.00351

7. Barron K, Athreya B, Kastner D. Periodic fever syndromes and other inherited autoinflammatory diseases. In: Cassidy JT, et al, eds. Textbook of pediatric rheumatology. 7th ed. Elsevier Saunders; 2015. P. 609-41.

8. Toplak N, Frenkel J, Ozen S, et al. An international registry on autoinflammatory diseases: the Eurofever experience. Ann Rheum Dis. 2012;71:1177-82. doi: 10.1136/annrheumdis-2011-200549

9. Гатторно М. Аутовоспалительные заболевания у детей. Вопросы современной педиатрии. 2014;13:55-64 [Gattorno M. Autoinflammatory diseases in children. Voprosy Sovremennoi Pediatrii. 2014;13:55-64 (In Russ.)].

10. Federici S, Gattorno M. A practical approach to the diagnosis of autoinflammatory diseases in childhood. Best Pract Res Clin Rheumatol. 2014;28:263-76. doi: 10.1016/j.berh.2014.05.005

11. Federici S, Sormani M, Ozen S, et al. Evidence-based provisional clinical classification criteria for autoinflammatory periodic fevers. Ann Rheum Dis. 2015;74:799-805. doi: 10,1136/annrheumdis-2014-206580

12. International Study Group for Behcet's disease. Criteria for diagnosis of Behcet's disease. Lancet. 1990;335:1070-80.

13. Yalcinskaya F, Ozen S, Ozcakar ZB, et al. A new set of criteria for the diagnosis of familial Mediterranean fever in childhood. Rheumatology (Oxford). 2009;48(4):395-8. doi: 10.1093/rheumatology/ken509

14. Ter Haar N, Oswald M, Jeyaratnam J, et al. Recommendation for the management of autoinflammatory diseases. Ann Rheum Dis. 2015;74:1636-44. doi: 10,1136/annrheumdis-2015-207546

15. Салугина СО, Федоров ЕС, Захарова ЕЮ, Евсикова МД. Семейный случай синдрома Muckle–Wells в российской популяции: первые успех и терапии ингибитором интерлейкина 1 канакинумабом. Современная ревматология. 2015;9(1):66-71 [Salugina SO, Fedorov ES, Zakharova EYu, Evsikova MD. A familial case of Muckle-Wells syndrome in a Russian population: The first successes of therapy with the interleukin 1 inhibitor canakinumab. Sovremennaya Revmatologiya = Modern Rheumatology Journal. 2015;9(1):66-71. (In Russ.)]. doi: 10.14412/1996-7012-2015-1-66-71

16. Алекберова ЗС. Болезнь Бехчета у детей. Вопросы современной педиатрии. 2009;8(6):64-70 [Alekberova ZS. Behcet’s disease in children. Voprosy Sovremennoi Pediatrii. 2009;8(6):64-70 (In Russ.)].

17. Кузьмина НН, Федоров ЕС, Салугина СО, Алекберова ЗС. Болезнь Бехчета у детей (российский опыт). Научно-практическая ревматология. 2015;53(3):312-8 [Kuzmina NN, Fedorov ES, Salugina SO, Alekberova ZS. Behcet’s disease in children: Russian experience. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2015;53(3):312-8 (In Russ.)]. doi: 10.14412/1995-4484-2015-312-318

18. Marshall KM, Edwards GS, Lawton AR. PFAPA syndrome. Pediatr Infect Dis J. 1989,8:658-9. doi: 10.1097/00006454-198909000-00026

19. Padeh S, Brezniak N, Zemer D, et al. Periodic fever, apthous stomatitis, pharyngitis, and adenopathy syndrome: clinical characteristics and outcome. J Pediatr. 1999;135:98-101. doi: 10.1016/S0022-3476(99)70335-5

20. Blau EB. Familial granulomatous arthritis, iritis, and rash. J Pediatr. 1985;107(5):689-93. doi: 10.1016/S0022-3476(85)80394-2